• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物与金属的结合。第3部分。铜(II)和锌(II)与异烟肼的相互作用。

Metal binding by pharmaceuticals. Part 3. Copper (II) and zinc (II) interactions with isoniazid.

作者信息

Cole A, May P M, Williams D R

出版信息

Agents Actions. 1983 Feb;13(1):91-7. doi: 10.1007/BF01994289.

DOI:10.1007/BF01994289
PMID:6858791
Abstract

Formation constants for copper(II) and zinc(II) complexes of isonicotinoylhydrazine (isoniazid) and guanosine-5'-monophosphate have been measured potentiometrically at 37 degrees C, I = 150 mmol dm-3 [NaCl]. These constants have been used in computer models to assess the extent of complex formation by the drug in vivo. The simulations indicate that the predominant complexes existing in blood plasma are ternary species formed with histidinate. However, at clinical levels of isoniazid, it seems unlikely that these complexes are physiologically significant. On the other hand, ternary complex formation with nucleosides may be involved in the binding of isoniazid to viral RNA.

摘要

已在37℃、离子强度I = 150 mmol dm⁻³[NaCl]条件下,通过电位滴定法测定了异烟酰肼(异烟肼)和鸟苷-5'-单磷酸与铜(II)和锌(II)形成配合物的形成常数。这些常数已用于计算机模型,以评估该药物在体内形成配合物的程度。模拟结果表明,血浆中存在的主要配合物是与组氨酸形成的三元物种。然而,在异烟肼的临床剂量水平下,这些配合物似乎不太可能具有生理意义。另一方面,与核苷形成三元配合物可能参与异烟肼与病毒RNA的结合。

相似文献

1
Metal binding by pharmaceuticals. Part 3. Copper (II) and zinc (II) interactions with isoniazid.药物与金属的结合。第3部分。铜(II)和锌(II)与异烟肼的相互作用。
Agents Actions. 1983 Feb;13(1):91-7. doi: 10.1007/BF01994289.
2
Metal binding by pharmaceuticals. Part 1. Copper(II) and zinc(II) interactions following ethambutol administration.药物与金属的结合。第1部分。乙胺丁醇给药后铜(II)和锌(II)的相互作用。
Agents Actions. 1981 May;11(3):296-305. doi: 10.1007/BF01967631.
3
Metal binding by pharmaceuticals. Part 2. Interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192.药物与金属的结合。第2部分。Ca(II)、Cu(II)、Fe(II)、Mg(II)、Mn(II)和Zn(II)与抗肿瘤药物ICRF 159及其无活性同系物ICRF 192的细胞内水解产物的相互作用。
Agents Actions. 1982 Oct;12(4):536-42. doi: 10.1007/BF01965940.
4
Quantitative investigation of copper(II) and zinc(II) complexes with S-carboxymethyl-L-cysteine and computer-simulated appraisal of their potential significance in vivo.铜(II)和锌(II)与S-羧甲基-L-半胱氨酸配合物的定量研究及其在体内潜在意义的计算机模拟评估
J Inorg Biochem. 1989 Dec;37(4):309-23. doi: 10.1016/0162-0134(89)85005-6.
5
Binary and ternary mixed metal complexes of terminally free peptides containing two different histidyl binding sites.含两个不同组氨酸结合位点的端基无自由肽的二元和三元混合金属配合物。
J Inorg Biochem. 2013 Nov;128:17-25. doi: 10.1016/j.jinorgbio.2013.07.008. Epub 2013 Jul 16.
6
Z-DNA is formed by poly (dC-dG) and poly (dm5C-dG) at micro or nanomolar concentrations of some zinc(II) and copper(II) complexes.
J Biomol Struct Dyn. 1985 Jun;2(6):1205-20. doi: 10.1080/07391102.1985.10507633.
7
An assessment of the physiological significance of cimetidine interactions with copper and zinc in biofluids as based on the computer-simulated distribution of the involved complexes at therapeutic levels of the drug.基于计算机模拟药物治疗水平下相关络合物的分布,对西咪替丁与生物流体中铜和锌相互作用的生理意义进行评估。
Agents Actions. 1984 Dec;15(5-6):649-59. doi: 10.1007/BF01966787.
8
Selective binding behavior of zinc(II) and copper(II) ions to their native sites of apo-bovine superoxide dismutase.锌(II)和铜(II)离子与脱辅基牛超氧化物歧化酶天然位点的选择性结合行为。
Biochem Int. 1984 Mar;8(3):401-8.
9
Disruption of zinc and copper interactions with Aβ(1-40) by a non-toxic, isoniazid-derived, hydrazone: a novel biometal homeostasis restoring agent in Alzheimer's disease therapy?一种无毒的、源自异烟肼的腙对锌和铜与Aβ(1 - 40)相互作用的破坏:阿尔茨海默病治疗中一种新型的生物金属稳态恢复剂?
Metallomics. 2015 May;7(5):743-7. doi: 10.1039/c5mt00003c. Epub 2015 Apr 10.
10
Copper and zinc binding properties of the N-terminal histidine-rich sequence of Haemophilus ducreyi Cu,Zn superoxide dismutase.杜克嗜血杆菌铜锌超氧化物歧化酶N端富含组氨酸序列与铜和锌的结合特性
J Inorg Biochem. 2008 Sep;102(9):1700-10. doi: 10.1016/j.jinorgbio.2008.04.007. Epub 2008 May 6.

引用本文的文献

1
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity.铜的协同毒性导致 NAT2 相关异烟肼毒性。
Exp Mol Med. 2024 Mar;56(3):570-582. doi: 10.1038/s12276-024-01172-8. Epub 2024 Mar 1.
2
Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.光学相干断层扫描可测量乙胺丁醇所致视神经病变患者的轴突损失。
Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):410-6. doi: 10.1007/s00417-004-1053-1. Epub 2004 Nov 23.
3
Metal binding by pharmaceuticals. Part 4. A comparative investigation of the interaction of metal ions with hydralazine, prizidilol and related compounds.

本文引用的文献

1
Enhancement by transition metals of chromosome aberrations induced by isoniazid.过渡金属对异烟肼诱导的染色体畸变的增强作用。
Biochem Pharmacol. 1980 Mar 1;29(5):842-5. doi: 10.1016/0006-2952(80)90571-7.
2
Mode of action of isonicotinic hydrazide.异烟肼的作用方式。
Nature. 1955 Jul 2;176(4470):34-5. doi: 10.1038/176034a0.
3
The influence of copper on the uptake of hydrazides.
Aust J Exp Biol Med Sci. 1962 Jun;40:201-5. doi: 10.1038/icb.1962.23.
药物与金属的结合。第4部分。金属离子与肼屈嗪、普尼地洛及相关化合物相互作用的比较研究。
Agents Actions. 1984 Jan;14(1):113-20. doi: 10.1007/BF01966843.
4
Metal binding by pharmaceuticals. Part 5. Interaction of Cd(II), Ni(II) and Pb(II) with the intracellular hydrolysis products of the anti-tumour agent ICRF 159 and its inactive homologue ICRF 192.药物与金属的结合。第5部分。镉(II)、镍(II)和铅(II)与抗肿瘤药物ICRF 159及其无活性同系物ICRF 192的细胞内水解产物的相互作用。
Agents Actions. 1984 Oct;15(3-4):448-53. doi: 10.1007/BF01972386.
5
Metal ion-tetracycline interactions in biological fluids. Part 5. Formation of zinc complexes with tetracycline and some of its derivatives and assessment of their biological significance.生物流体中的金属离子 - 四环素相互作用。第5部分。锌与四环素及其一些衍生物形成的配合物及其生物学意义评估。
Agents Actions. 1985 Dec;17(2):229-42. doi: 10.1007/BF01966597.
4
Metal-catalysed auto-oxidation of isoniazid.异烟肼的金属催化自动氧化
Biochem J. 1959 Nov;73(3):500-7. doi: 10.1042/bj0730500.
5
Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid.分枝杆菌中的过氧化氢酶和过氧化物酶。与异烟肼作用方式的可能关系。
Am Rev Respir Dis. 1960 Jan;81:68-78. doi: 10.1164/arrd.1960.81.1P1.68.
6
The uptake of isoniazid by washed cell suspensions of Mycobacteria and other organisms.分枝杆菌及其他生物体的洗涤细胞悬液对异烟肼的摄取。
Aust J Exp Biol Med Sci. 1958 Jun;36(3):223-33. doi: 10.1038/icb.1958.24.
7
Metal chelates and antitubercular activity. IV. Isonicotinyl hydrazide.金属螯合物与抗结核活性。IV. 异烟酰肼。
J Am Pharm Assoc Am Pharm Assoc. 1958 Apr;47(4):285-8. doi: 10.1002/jps.3030470419.
8
Mode of action of isoniazid.
Nature. 1956 Mar 17;177(4507):525-6. doi: 10.1038/177525a0.
9
A proposed mode of action for isoniazid in the tubercle bacillus and other biological systems.
Am Rev Tuberc. 1954 Jun;69(6):1062-3.
10
The affinity of isonicotinic hydrazide for metals.
Experientia. 1953 Oct 15;9(10):370. doi: 10.1007/BF02167635.